Ignite Creation Date:
2024-05-06 @ 8:07 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06267274
Status:
RECRUITING
Last Update Posted:
2024-03-29
First Post:
2024-02-12
Brief Title:
A Randomized Double-blind Parallel-group Two-arm Multiple Dose Multicenter Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes
Sponsor:
Amneal Pharmaceuticals LLC
Organization:
Amneal Pharmaceuticals LLC
Organization Data
Organization:
Amneal Pharmaceuticals LLC
Class:
INDUSTRY
Study ID:
MW230021
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Amneal Pharmaceuticals LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| CBCC Global Inc | UNKNOWN |
| Amneal EU Limited | UNKNOWN |